Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Treatment of early aggressive rheumatoid arthritis (TEAR)

Trial Profile

Treatment of early aggressive rheumatoid arthritis (TEAR)

Completed
Phase of Trial: Phase IV

Latest Information Update: 17 May 2016

At a glance

  • Drugs Etanercept (Primary) ; Hydroxychloroquine (Primary) ; Methotrexate (Primary) ; Sulfasalazine (Primary)
  • Indications Rheumatoid arthritis
  • Focus Therapeutic Use
  • Acronyms TEAR
  • Most Recent Events

    • 25 Nov 2015 Results (assessing long term changes in cholesterol levels) published in the Arthritis and Rheumatology (n = 416).
    • 28 May 2011 Results presented at the 12th Annual Congress of the European League Against Rheumatism.
    • 16 Jun 2010 Results were presented at the 11th Annual Congress of the European League Against Rheumatism.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top